Trial·ClinicalTrials.gov
Phase II protocol amendment — KRAS G12C, NSCLC, expanded cohort
Healthcare & biotech intelligence
Quorvex is a healthcare and biotech intelligence platform.
Public plan prices
Full plan details- Starter
$250
per month
or $2,700/year
- Team
$2,250
per month
or $24,300/year
- Enterprise
From $6,500
per month
or $70,200/year
Quorvex combines AI-native intelligence across clinical trials, regulators, drugs and approvals, and competitors in one subscription. It ingests feeds from FDA, EMA, MHRA, ClinicalTrials.gov, peer-reviewed publications, and public corporate disclosures. Agentic AI extracts, summarises, and routes signals by therapeutic area, indication, sponsor, or modality — so your team sees what matters before it hits press release.
- 4
- streams unified
- 6+
- authoritative sources
- 1
- transparent subscription
Live signal feed
Real-time alerts, routed by your subscriptions
● live
12 min ago
Regulatory·FDA
Advisory committee vote scheduled — gene therapy, Class III
Approval·Company filing
Label expansion granted — anti-CD20, third-line indication
Regulatory·EMA
CHMP positive opinion — GLP-1 oral formulation
Competitor·PubMed
Analyst-curated brief: competitive landscape — bispecifics, hematology
Now piloting
Real-time FDA monitoring — live with select partners.
We're piloting sub-minute FDA action capture with a small group of regulatory and BD teams. If recalls, advisories and approvals are table stakes for your team, you should be in the pilot — we're onboarding a few more partners before general availability.
Sub-minute FDA action capture
Recall notices, advisory committee votes, drug safety communications and complete response letters — pushed to your dashboard before the press release.
Recall & advisory alerts in your digest
Sponsor- and indication-filtered. Quiet hours respected. No paging your on-call at 3am for a competitor filing.
Sponsor & indication routing
Subscribe to the entities you cover; FDA monitoring collapses into the same unified feed you already use for trials and approvals.
Pilot slots: 5 remaining this quarter.
FDA monitor — live
Pilot instrumented feed, last 60 seconds
live
events / 60s14 captured
FDA·Recall
Class II recall posted — infusion pump firmware, manufacturer XYZ
FDA·Advisory
Drug safety communication — label update, oral anticoagulant cohort
FDA·Approval
New molecular entity approved — orphan designation, rare neuromuscular
Illustrative snapshot for the public site. Pilot-partner dashboards render a live stream from monitored FDA sources — recall notices, advisory committee notices, drug safety communications, and approval letters.
The four streams
Four feeds your team pays for separately. One unified subscription.
Today, most biotech & pharma teams license Contify, AlphaSense, and Citeline as separate contracts. Quorvex consolidates them behind a single API and a single dashboard — with the same coverage, transparent mid-market pricing.
Clinical trials
Protocol amendments, enrollment shifts, endpoint changes, readouts — before they hit press release.
Sources
- ClinicalTrials.gov
- EU CTR
- WHO ICTRP
- Sponsor portals
✓approved
Regulators
FDA, EMA, MHRA — advisory committee votes, type-A meetings, priority review designations, complete response letters.
Sources
- FDA Drugs
- FDA Devices
- EMA EPAR
- MHRA
Drugs & approvals
New molecular entity approvals, label expansions, generic entries, REMS updates — every decision captured.
Sources
- Orange Book
- EPAR
- SPL
- Drug@FDA
Competitors
Public corporate disclosures, peer-reviewed publications, earnings call flow — routed by sponsor, indication, modality.
Sources
- SEC filings
- PubMed
- Earnings calls
- Investor decks
Filter by:
Competitive intelligence
Regulatory affairs
Business development
Clinical operations
Investor relations
Pipeline strategy
How it works
From source filing to your inbox — in minutes.
Agentic AI does the heavy lifting. You subscribe to what matters; we route what matches.
- 01
Ingest
Continuous, monitored pulls from FDA, EMA, MHRA, ClinicalTrials.gov, peer-reviewed journals, and corporate disclosures.
- 02
Extract
Agentic AI parses dense filings into structured signal records — sponsor, indication, modality, phase, geography.
- 03
Route
Subscribe by therapeutic area, indication, sponsor, or modality. Signal or quiet hours — your call.
- 04
Deliver
Real-time alerts in the dashboard, AI digests in your inbox, weekly analyst briefs, and CRO-ready exports for your stack.
Pricing
Three plans. Four streams. No per-seat math.
Mid-market transparent pricing — built for teams that pay real money for enterprise licensing elsewhere. No per-seat math, no surprise overage.
Compare plans
What's in each plan.
Every capability the way we measure it — line by line. No asterisks.
| Capability | Starter | Team | Enterprise |
|---|---|---|---|
| Seats | 3 total | 15 total | Unlimited |
| All four streams included (EMA/MHRA depth scales by tier). | Included | Included | Included |
| API rate limits | — | coming soon | Custom |
| Export formats | CSV | CSV + JSON | CSV + JSON + Parquet |
| Support SLA | Email — best-effort | Email — 1 business day | 24/7 + named CSM |
Frequently asked
Questions buyers ask before signing.
One subscription that replaces four.
Replace Contify + AlphaSense + Citeline with a single, AI-native feed. Talk to us — we will share a one-week curated signal preview from the live platform on your therapeutic area before any commitment.
Start with StarterProcurement support
Quorvex is operated by Aura Dynamics Group LLC, a Georgia LLC. View legal details.
Founder
Brandon Thomas
I built Quorvex to make the data teams need easier to access and more affordable. By using AI to bring trusted intelligence into a dashboard that fits their workflows, I want teams to spend less time searching and more time making informed decisions.